Page last updated: 2024-10-29

isoproterenol and Hypertrophy, Right Ventricular

isoproterenol has been researched along with Hypertrophy, Right Ventricular in 11 studies

Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.

Hypertrophy, Right Ventricular: Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.

Research Excerpts

ExcerptRelevanceReference
"Gene expression of heparanase, matrix metalloproteinases (MMP)-2 and MMP-9 were examined in ventricles after chronic treatment with isoproterenol (ISO) induced cardiac hypertrophy in rats."7.73Induction of heparanase gene expression in ventricular myocardium of rats with isoproterenol-induced cardiac hypertrophy. ( Hara, Y; Hashizume, K; Ito, R; Kizaki, K; Mutoh, K; Okada, M; Yoshioka, K, 2005)
"Gene expression of heparanase, matrix metalloproteinases (MMP)-2 and MMP-9 were examined in ventricles after chronic treatment with isoproterenol (ISO) induced cardiac hypertrophy in rats."3.73Induction of heparanase gene expression in ventricular myocardium of rats with isoproterenol-induced cardiac hypertrophy. ( Hara, Y; Hashizume, K; Ito, R; Kizaki, K; Mutoh, K; Okada, M; Yoshioka, K, 2005)
"Rats treated with monocrotaline (MCT) develop pulmonary hypertension."3.72Mechanical load-dependent regulation of gene expression in monocrotaline-induced right ventricular hypertrophy in the rat. ( Brodde, OE; Hartmann, O; Hasenfuss, G; Kögler, H; Leineweber, K; Nguyen van, P; Schott, P, 2003)
"The study consisted of six groups (N=30; five rabbits/group): (1) Control with no pretreatment, monocrotaline injected groups: (solutions were perfused following termination of CPB for 60 min); (2) Control for pulmonary hypertension (PHT); (3) isoproteronol; (4) VIP 10(-6) M; (5) VIP 10(-5) M; (6) nitroglycerine."3.71The effects of vasoactive intestinal peptide on monocrotaline induced pulmonary hypertensive rabbits following cardiopulmonary bypass: a comparative study with isoproteronol and nitroglycerine. ( Chang, D; Gunaydin, S; Hagino, I; Imai, Y; Seo, K; Shinoka, T; Takanashi, Y, 2002)
"We used a mouse model of Chuvash polycythemia (CP), a rare genetic disorder that modestly increases expression of HIF target genes in normoxia, to understand what these effects might be within the heart."1.43The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high-energy phosphate metabolism. ( Carr, C; Clarke, K; Cole, M; Curtis, MK; Dodd, M; Giles, L; Heather, LC; Robbins, PA; Slingo, M; Tyler, D, 2016)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (27.27)18.2507
2000's6 (54.55)29.6817
2010's2 (18.18)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Power, AS1
Hickey, AJ1
Crossman, DJ1
Loiselle, DS1
Ward, ML1
Slingo, M1
Cole, M1
Carr, C1
Curtis, MK1
Dodd, M1
Giles, L1
Heather, LC1
Tyler, D1
Clarke, K1
Robbins, PA1
Gupta, SC1
Varian, KD1
Bal, NC1
Abraham, JL1
Periasamy, M1
Janssen, PM1
Kögler, H1
Hartmann, O1
Leineweber, K1
Nguyen van, P1
Schott, P1
Brodde, OE1
Hasenfuss, G1
Kiriazis, H1
Du, XJ1
Feng, X1
Hotchkin, E1
Marshall, T1
Finch, S1
Gao, XM1
Lambert, G1
Choate, JK1
Kaye, DM1
Kizaki, K1
Okada, M1
Ito, R1
Yoshioka, K1
Hashizume, K1
Mutoh, K1
Hara, Y1
Kuramochi, T1
Honda, M1
Tanaka, K1
Enomoto, K1
Hashimoto, M1
Morioka, S1
Gwathmey, JK1
Morgan, JP1
Eddahibi, S1
Raffestin, B1
Le Monnier de Gouville, AC1
Adnot, S1
León-Velarde, F1
Bourin, MC1
Germack, R1
Mohammadi, K1
Crozatier, B1
Richalet, JP1
Gunaydin, S1
Imai, Y1
Takanashi, Y1
Seo, K1
Hagino, I1
Chang, D1
Shinoka, T1

Other Studies

11 other studies available for isoproterenol and Hypertrophy, Right Ventricular

ArticleYear
Calcium mishandling impairs contraction in right ventricular hypertrophy prior to overt heart failure.
    Pflugers Archiv : European journal of physiology, 2018, Volume: 470, Issue:7

    Topics: Animals; Calcium; Heart Failure; Heart Ventricles; Hypertension, Pulmonary; Hypertrophy, Right Ventr

2018
The von Hippel-Lindau Chuvash mutation in mice alters cardiac substrate and high-energy phosphate metabolism.
    American journal of physiology. Heart and circulatory physiology, 2016, 09-01, Volume: 311, Issue:3

    Topics: Adenosine Triphosphate; Animals; Apoptosis Regulatory Proteins; Aryl Hydrocarbon Receptor Nuclear Tr

2016
Pulmonary artery banding alters the expression of Ca2+ transport proteins in the right atrium in rabbits.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:6

    Topics: Animals; Calcium; Cardiotonic Agents; Heart Atria; Hypertrophy, Right Ventricular; Isoproterenol; Ma

2009
Mechanical load-dependent regulation of gene expression in monocrotaline-induced right ventricular hypertrophy in the rat.
    Circulation research, 2003, Aug-08, Volume: 93, Issue:3

    Topics: Actin Cytoskeleton; Adrenergic beta-Agonists; Animals; Biomechanical Phenomena; Body Weight; Calcium

2003
Preserved left ventricular structure and function in mice with cardiac sympathetic hyperinnervation.
    American journal of physiology. Heart and circulatory physiology, 2005, Volume: 289, Issue:4

    Topics: Adrenergic beta-Agonists; Animals; Echocardiography; Female; Gene Expression; Heart; Hypertrophy, Ri

2005
Induction of heparanase gene expression in ventricular myocardium of rats with isoproterenol-induced cardiac hypertrophy.
    Biological & pharmaceutical bulletin, 2005, Volume: 28, Issue:12

    Topics: Animals; Blotting, Northern; Cardiomegaly; Disease Models, Animal; Drug Administration Schedule; Enz

2005
Calcium transients in single myocytes and membranous ultrastructures during the development of cardiac hypertrophy and heart failure in rats.
    Clinical and experimental pharmacology & physiology, 1994, Volume: 21, Issue:12

    Topics: Animals; Calcium; Cell Membrane; Heart Failure; Hypertrophy, Right Ventricular; Isometric Contractio

1994
Sarcoplasmic reticulum calcium mobilization in right ventricular pressure-overload hypertrophy in the ferret: relationships to diastolic dysfunction and a negative treppe.
    Pflugers Archiv : European journal of physiology, 1993, Volume: 422, Issue:6

    Topics: Action Potentials; Animals; Caffeine; Calcium; Diastole; Electric Stimulation; Ferrets; Hypertrophy,

1993
Effect of DMPPO, a phosphodiesterase type 5 inhibitor, on hypoxic pulmonary hypertension in rats.
    British journal of pharmacology, 1998, Volume: 125, Issue:4

    Topics: Allopurinol; Animals; Atrial Natriuretic Factor; Cyclic GMP; Drug Interactions; Hypertension, Pulmon

1998
Differential alterations in cardiac adrenergic signaling in chronic hypoxia or norepinephrine infusion.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2001, Volume: 280, Issue:1

    Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Cholera Toxin; Chroni

2001
The effects of vasoactive intestinal peptide on monocrotaline induced pulmonary hypertensive rabbits following cardiopulmonary bypass: a comparative study with isoproteronol and nitroglycerine.
    Cardiovascular surgery (London, England), 2002, Volume: 10, Issue:2

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Calcium Channel Blockers; Cardiopulm

2002